Skip Navigation

Interstitial laser therapy for fibroadenomas of the breast

Guidance issued Guidance issued
 
IP Guidance Number: IPG131
 
Summary:

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on interstitial laser therapy for fibroademomas of the breast.

Description:

A fibroadenoma is a benign (non-cancerous) solid lump of tissue, which is thought to result from increased sensitivity to the hormone oestrogen. It normally has a rubbery texture, is smooth to the touch and moves easily under the skin. Fibroadenomas are very common and it is not unusual to have more than one. They are mostly found in young women but can occur in women of any age.

Laser therapy aims to destroy the tissue that has formed the fibroadenoma by the use of high-energy light. In this technique laser light is delivered to the lesion(s) via fibres positioned through needles inserted percutaneously into the breast under local anaesthetic, and guided to the fibroadenoma by imaging equipment, usually ultrasound. The presterilised bare fibre is passed a short distance beyond the tip of the needle, and laser energy is delivered through this fibre. The energy is delivered in continuous wave mode for a few minutes. For larger lesions multiple needles are inserted 1 cm apart, with a laser fibre through each.

The potential benefits of interstitial laser therapy are possibly lower rates of infection than open surgery, and a more acceptable aesthetic result.

Arrangements:

Other (see guidance)

Topic Area:

Gynaecology, pregnancy and birth
Surgical procedures

Specialty:

General surgery

Specialist advice has
been sought from:

British Association of Surgical Oncology

Royal College of Radiologists

British Society of Interventional Radiologists

Date notified to NICE: 18 June 2004
Provisional Consultation Date: March 2005
Guidance Publication Date: 22 June 2005
Contact Details:
Project Manager
(for general enquiries or comments)
Ben Doak
Technical Lead
(for procedure specific enquiries or comments)
Steven Barnes
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA


Links:

Search NICE guidance


Advanced guidance search

Related information

See NICE guidance in practice

Related guidance

Click the links below to see guidance on similar topics